CM
ABBV icon

CS McKee’s AbbVie ABBV Stock Holding History

CS McKee’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-600,686
Closed -$31.7M – 122
2013
Q4 		$31.7M Sell
600,686
-27,257
-4% -$1.34M 0.62% 51
2013
Q3 		$28.1M Sell
627,943
-18,200
-3% -$807K 0.48% 64
2013
Q2 		$26.7M Buy
+646,143
New +$28.3M 0.45% 66

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

CS McKee's ABBV Position: Q1 2014 in Review

CS McKee sold out of AbbVie (ABBV) in Q1 2014, closing a stake of 600,686 shares — an estimated $31.7M sold.

CS McKee first reported a position in ABBV in Q2 2013 and held it in 3 quarters. The position peaked at $31.7M in Q4 2013. 1,422 funds tracked by Wall St. Rank hold ABBV as of Q1 2014.

  • CS McKee reported no remaining AbbVie position as of Q1 2014 after selling out during the quarter.
  • CS McKee sold 600,686 AbbVie shares in Q1 2014, an estimated $31.7M.
  • CS McKee first reported a position in AbbVie in Q2 2013 and held it in 3 quarters.
  • CS McKee's AbbVie position peaked at $31.7M in Q4 2013.
  • 1,422 funds tracked by Wall St. Rank held AbbVie as of Q1 2014.

Based on CS McKee's 13F filing for Q1 2014, filed 14 May 2014.